The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.

康复之路：对马拉维癌症幸存者患者报告的生活质量的评估。

• 批准号: 10428019
• 负责人: Carla J Chibwesha
• 金额: $ 19.06万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-13 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10428019
• 关键词: Administrative Supplement; Aftercare; Cancer Control; Cancer Survivor; Cancer Survivorship; Cohort Studies; Country; Diagnosis; Early Diagnosis; Enrollment; Equilibrium; Goals; Individual; Intervention; Kaposi Sarcoma; Life; Lymphoma; Malawi; Malignant Neoplasms; Measures; Mental Health; Outcome; Patient Outcomes Assessments; Patients; Physical Function; Population; Quality of life; Recovery; Reporting; Resources; Survivors; Time; Translating; cancer care; cancer survival; cancer therapy; cancer type; comparison group; experience; health related quality of life; improved; patient oriented; prospective; survivorship

PROJECT SUMMARY/ABSTRACT: Increasing efforts to improve early detection, diagnosis, and treatment of cancers in low resourced countries have led to modest improvements in cancer survival and given rise to an expanding population of cancer survivors. However, there is a gap in the understanding of cancer survivorship in low resourced countries. The goal of this proposal is to measure health-related quality of life (HRQoL) for cancer survivors with Kaposi sarcoma (KS) and lymphoma across the continuum of cancer care in Malawi. In line with NCI's definition of a cancer survivor, our survivor population includes any individual diagnosed with cancer from the time of diagnosis through the balance of life. We hypothesize that: a) KS and lymphoma survivors will have differences in mental health and physical function domains of HRQoL before (pre-), during (mid-), and up to 1 year after (post-) cancer-directed treatment; and b) there is no difference in post-treatment HRQoL among short-term (< 1 year since treatment completion), medium-term (≥1-5 years since treatment completion) or long-term (> 5 year since treatment completion) survivors.

项目概要/摘要： 加大力度改善资源匮乏国家癌症的早期检测、诊断和治疗 导致癌症生存率略有改善，并导致癌症人口不断增加 然而，资源匮乏国家对癌症幸存者的理解存在差距。 该提案的目标是衡量卡波西癌症幸存者的健康相关生活质量 (HRQoL) 马拉维癌症治疗过程中的肉瘤 (KS) 和淋巴瘤 符合 NCI 对癌症的定义。 癌症幸存者，我们的幸存者群体包括自癌症发生以来被诊断患有癌症的任何个人 我们勇敢地认为：a) KS 和淋巴瘤幸存者会有差异。 HRQoL 之前（前）、期间（中）以及之后 1 年内的心理健康和身体功能领域 （后）癌症定向治疗；b) 短期治疗后 HRQoL 没有差异（< 自治疗完成后 1 年）、中期（自治疗完成后≥1-5 年）或长期（> 5 自治疗完成后一年）幸存者。